Suretech Medical Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 2.50 Cr
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.60 Cr
- Revenue Growth %
- Profit Growth 50.57%
- Ebitda 60.97%
- Net Worth 5573.94%
- Total Assets 1521.23%
About Suretech Medical
Suretech Medical Private Limited (SMPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 April 2015 (Nine years and nine months 25 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 2.50 Cr.
The company currently has active open charges totaling ₹19.60 Cr.
Nipul Jain, Usha Nipulkumar, and Neev Jain serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999MH2015PTC263679
-
Company No.
263679
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Apr 2015
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Suretech Medical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nipul Jain
|
Director | 22-Apr-2015 | Current |
|
Usha Nipulkumar
|
Director | 22-Apr-2015 | Current |
|
Neev Jain
|
Director | 09-Oct-2021 | Current |
Financial Performance of Suretech Medical.
Suretech Medical Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 50.57% increase in profit. The company's net worth Soared by an impressive increase of 5573.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Suretech Medical?
In 2023, Suretech Medical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹19.60 Cr
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 19.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Sep 2023 | Bank Of India | ₹9.80 Cr | Open |
| 16 Sep 2023 | Bank Of India | ₹9.80 Cr | Open |
How Many Employees Work at Suretech Medical?
Unlock and access historical data on people associated with Suretech Medical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suretech Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suretech Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.